Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Goodwill & Intangibles: 2019-2024

Historic Goodwill & Intangibles for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $9.7 million.

  • Silence Therapeutics' Goodwill & Intangibles rose 12.18% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 12.18%. This contributed to the annual value of $9.7 million for FY2024, which is 6.18% down from last year.
  • Per Silence Therapeutics' latest filing, its Goodwill & Intangibles stood at $9.7 million for FY2024, which was down 6.18% from $10.3 million recorded in FY2023.
  • Silence Therapeutics' 5-year Goodwill & Intangibles high stood at $10.6 million for FY2021, and its period low was $9.7 million during FY2024.
  • Its 3-year average for Goodwill & Intangibles is $10.0 million, with a median of $10.1 million in 2022.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first grew by 6.22% in 2020, then declined by 6.18% in 2024.
  • Yearly analysis of 5 years shows Silence Therapeutics' Goodwill & Intangibles stood at $10.6 million in 2020, then rose by 0.51% to $10.6 million in 2021, then dropped by 5.13% to $10.1 million in 2022, then rose by 2.62% to $10.3 million in 2023, then decreased by 6.18% to $9.7 million in 2024.